Why ODF Projects Need “Equipment Power” to Scale from Lab to GMP
Share
Many oral dissolvable film (ODF) projects succeed in the laboratory stage, but struggle when transitioning to GMP-scale production. Issues such as unstable films, inconsistent content, drying failures, and sudden drops in yield are common. One root cause is the technology gap between lab-scale and production-scale equipment. To achieve a smooth R&D-to-GMP transition, strong “equipment power” is needed to bridge the gap.
Common “R&D Disconnection” Problems
- Lab coating methods differ from production-scale machines, making parameters invalid
- Drying, tension control, and liquid supply systems are not aligned with actual production
- Lack of in-line detection systems, leading to non-traceable and non-auditable data
- Lab environments often fail to meet GMP cleanliness standards, limiting regulatory support
How Equipment Supports the Lab-to-GMP Transition
- Adopt pilot equipment such as MJ150-L, designed with the same principles as GMP machines, to validate scale-up processes in advance
- Equip systems with in-line thickness measurement, automatic tension control, and closed liquid supply for consistent data
- Enable data collection and export functions to meet audit trail requirements
- Record complete process parameters to support registration and export filing
Recommended Equipment:
Related product
MJ150 ODF & Transdermal Patch Film Making Machine
Doctor-blade coating, 0.2–5 m/min running speed, drying from room temperature up to 120 °C.
HUANGHAI’s Lab-to-GMP Solutions
HUANGHAI offers a complete equipment ecosystem covering R&D, pilot, and commercial GMP stages:
- Pilot-scale: MJ150-L, enabling reproducible parameter migration for scale-up
- Commercial GMP: MJ150 with output of about 30,000 films/hour (Gen I), designed for GMP production
- Seamless integration with testing instruments, enabling a “manufacturing + testing” traceability loop
Conclusion
Success in ODF projects is not only about formulation — it is about process control and equipment alignment. Deploying pharmacopeia-grade pilot equipment and scale-up strategies early is the key to efficient market entry and successful regulatory approval.
*The MJ150 production line's patented hot-air drying tunnel (Academician Hou Huimin's patent CN201668734U).
Frequently Asked Questions
What is the difference between an ODF film and a transdermal patch?
Oral dissolving films (ODF) dissolve on or under the tongue within seconds to minutes; transdermal patches stick to the skin and release the API over hours to days. Both are made by solvent-cast film coating, and the MJ Pro coating platform can be built for either — the application is set before the machine is manufactured.
What output can I expect from Huanghai ODF machines?
MJ150-RD about 1,200 films per hour for formulation screening; MJ150-Lab 8,000–10,000 films per hour for pilot-scale work; MJ150 about 30,000 films per hour (Gen I) for commercial production. For packaging, the MJ180 cuts and packs about 11,900 films per hour (Gen I); the EZ320 (about 9,000 films per hour) is for food-grade films only.
What drying technology is used?
The MJ150 production line uses a patented hot-air parallel-flow drying tunnel (Academician Hou Huimin's patent CN201668734U). The MJ150-RD uses oven drying; the MJ150-Lab uses the same hot-air drying process as the MJ150.
Can Huanghai machines coat multi-formula (striped) films?
Yes. Huanghai's patent CN117323228A covers stripe coating that applies two formulations side by side in one pass, useful for fixed-dose combination films.
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from R&D (MJ150-RD / MJ150-Lab) to commercial manufacturing (MJ150). Designed for GMP production and to support 21 CFR Part 11 requirements.
Equipment Certifications & Regulatory Compliance
Huanghai manufactures under an ISO 9001:2015 quality management system, and CE-certified models are available. ODF production line equipment is designed to support 21 CFR Part 11 requirements.